DexCom (NASDAQ:DXCM) Price Target Raised to $106.00
DexCom (NASDAQ:DXCM – Free Report) had its target price hoisted by Canaccord Genuity Group from $103.00 to $106.00 in a research note issued to investors on Friday morning,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the medical device company’s stock. A number of other equities research analysts also recently weighed in on […]
DexCom (NASDAQ:DXCM – Free Report) had its target price hoisted by Canaccord Genuity Group from $103.00 to $106.00 in a research note issued to investors on Friday morning,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the medical device company’s stock. A number of other equities research analysts also recently weighed in on […]
